Dr. Aaron Michael Goodman, MD

Dr. Goodman practices at MountainView Hospital in Las Vegas, Nevada, part of HCA Healthcare.

Dr. Goodman's NPI, 1851603559, was assigned on July 9, 2010. Dr. Goodman graduated from Emory School of Medicine in 2010. Dr. Goodman holds California license A130400.

Dr. Goodman's primary practice is MountainView Hospital, at 3100 N Tenaya Way, Las Vegas, NV 89128 in Clark County. The practice phone is (702) 255-5000.

Dr. Goodman's primary practice is MountainView Hospital in Las Vegas, Nevada, part of HCA Healthcare. Dr. Goodman is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Goodman to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goodman practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Goodman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Goodman is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Goodman's licenses on file in 2 states: California and Missouri.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), fluid and electrolyte imbalances, immune deficiency disease, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Goodman treats.

CMS data shows 1,024 Medicare services from Dr. Goodman across 11 procedure codes in 2024, for 199 Medicare patients. Medicare paid $83,774 for them.

CMS counts 199 Medicare patients who saw Dr. Goodman in 2024. The largest group is 65 to 74, with 95 patients. 72% of them have high cholesterol, and 70% have high blood pressure. 29% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goodman's median patient age at 69, with 44% women.

In 2024, Dr. Goodman wrote 709 Medicare Part D claims for 67 patients. 70% of them were for generic drugs. CMS names the drug for 481 of them, across 20 drugs with 11 or more claims each, at $2,039,824 in total drug cost. In 2023, CMS named 328 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Goodman for performance year 2024, reported as part of a group. Dr. Goodman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 99 papers to Dr. Goodman, published from 2016 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Multiple Myeloma, Immunotherapy and Antineoplastic Agents. Dr. Goodman has published most often in Eur J Cancer. Dr. Goodman's most frequent co-authors are Shumei Kato, MB, Philip R. Cohen, MD and Edward D. Ball, MD.

CMS Open Payments shows 187 general payments to Dr. Goodman from 15 drug and device companies from 2016 to 2025. Grants make up the largest share, 40% of the total. Pfizer Inc. paid the most, $142,149.

Dr. Goodman graduated from Emory School of Medicine in 2010.

Dr. Goodman is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.